Medical - Devices industry analysis: EL7 Score and the best stocks ranked by value, profitability, and momentum.
68 of 152
P/E 26.5 vs period average 25.5 Richer than its history
Ranked among 54 stocks with a market cap above $500M. Smaller companies are excluded from the ranking.
Rank | Company | Price | P/E | Value | Growth | Quality | EL7 Score |
|---|---|---|---|---|---|---|---|
| 1/54 | ![]() | $81.83 | 21.0 | 83 | 77 | 93 | 100 |
| 2/54 | ![]() | $14.72 | 19.1 | 89 | 65 | 97 | 99 |
| 3/54 | ![]() | $47.68 | 25.8 | 90 | 31 | 78 | 98 |
| 4/54 | ![]() | $71.01 | 15.7 | 64 | 62 | 92 | 97 |
| 5/54 | ![]() | $78.57 | 31.1 | 42 | 75 | 96 | 96 |
| 6/54 | ![]() | $23.39 | 21.9 | 85 | 52 | 86 | 95 |
| 7/54 | ![]() | $80.62 | 23.8 | 66 | 73 | 79 | 95 |
| 8/54 | ![]() | $14.51 | 944.7 | 35 | 74 | 94 | 93 |
| 9/54 | ![]() | $13.72 | 11.2 | 98 | 4 | 84 | 92 |
| 10/54 | ![]() | $97.44 | 23.7 | 91 | 19 | 88 | 92 |
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
Insider purchases in the sector's stocks
Funds that track the sector and each fund's exposure to it.
Fund | Exposure | Assets | Expense |
|---|---|---|---|
| IBBiShares Biotechnology ETF | 100.0% | $11B | 0.44% |
| VHTVanguard Health Care ETF | 100.0% | $22B | 0.09% |
| IHIiShares U.S. Medical Devices ETF | 99.7% | $4B | 0.37% |
| XLVState Street Health Care Select Sector SPDR ETF | 99.1% | $47B | 0.08% |
The percentage is the sector's share of the fund's assets, per the latest available data.
Upgrades and downgrades on the sector's stocks